Skip to main content

Table 4 Patient characteristics

From: Unfractionated heparin in acute chest syndrome: a pilot feasibility randomized controlled trial of unfractionated heparin vs. standard of care in acute chest syndrome

 

Standard of care (N = 3)

Unfractionated heparin (N = 4)

Age (years)

32 ± 18.52

29.25 ± 3.77

25 (18, 53)

29 (26, 33)

Sex

Male

1 (33%)

2 (50%)

Female

2 (67%)

2 (50%)

Race

African American

3 (100%)

4 (100%)

Genotype

HbSS

1 (33%)

2 (50%)

HbSC

1 (33%)

2 (50%)

HbSβ0

1 (33%)

0 (0%)

Prior episode of ACS

3 (100%)

4 (100%)

Current hydroxyurea use

3 (100%)

4 (100%)

History of VTE

0 (0%)

0 (0%)

History of myocardial infarction

0 (0%)

0 (0%)

Chronic lung disease

0 (0%)

0 (0%)

History of stroke

0 (0%)

0 (0%)

Active tobacco use

2 (67%)

1 (25%)

  1. n (%) for categorical variables. Mean ± SD and median (Min, Max) for continuous variables
  2. Abbreviation: ACS acute chest syndrome, VTE venous thromboembolism